45782 Federal Register / Vol. 73, No. 152 / Wednesday, August 6, 2008 / Notices 

Drug Schedule 

Methamphetamine (1105) ............. II 

Phenmetrazine (1631) .................. II 

Methylphenidate (1724) ................ II 

Amobarbital (2125) ....................... II 

Pentobarbital (2270) ..................... II 

Secobarbital (2315) ...................... II 

Glutethimide (2550) ...................... II 

Phencyclidine (7471) .................... II 

Alphaprodine (9010) ..................... II 

Anileridine (9020) .......................... II 

Cocaine (9041) ............................. II 

Codeine (9050) ............................. II 

Dihydrocodeine (9120) ................. II 

Oxycodone (9143) ........................ II 

Hydromorphone (9150) ................. II 

Diphenoxylate (9170) .................... II 

Hydrocodone (9193) ..................... II 

Levorphanol (9220) ....................... II 

Meperidine (9230) ......................... II 

Methadone (9250) ........................ II 

Dextropropoxyphene, bulk (nondosage forms) (9273).II 

Morphine (9300) ........................... II 

Thebaine (9333) ........................... II 

Oxymorphone (9652) .................... II 

Noroxymorphone (9668) ............... II 

Alfentanil (9737) ............................ II 

Sufentanil (9740) .......................... II 

Fentanyl (9801) ............................. II 

The company plans to import 

reference standards for sale to 

researchers and analytical labs. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 952(a) 

and determined that the registration of 

United States Pharmacopeial 

Convention to import the basic classes 

of controlled substances is consistent 

with the public interest and with United 

States obligations under international 

treaties, conventions, or protocols in 

effect on May 1, 1971, at this time. DEA 

has investigated United States 

Pharmacopeial Convention to ensure 

that the company’s registration is 

consistent with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 952(a) 

and 958(a), and in accordance with 21 

CFR 1301.34, the above named company 

is granted registration as an importer of 

the basic classes of controlled 

substances listed. 

Dated: July 29, 2008. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E8–17965 Filed 8–5–08; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Registration 

By Notice dated April 9, 2008 and 

published in the Federal Register on 

April 16, 2008, (73 FR 20715), Research 

Triangle Institute, Kenneth H. Davis, Jr., 

Hermann Building, East Institute Drive, 

P.O. Box 12194, Research Triangle, 

North Carolina 27709, made application 

by renewal to the Drug Enforcement 

Administration (DEA) to be registered as 

an importer of the basic classes of 

controlled substances listed in 

schedules I and II: 

Drug Schedule 

1-(1-Phenylcyclohexyl)pyrrolidine 

(7458).

I 

1-[1-(2- 

Thienyl)cyclohexy]piperidine 

(7470).

I 

1-[1-(2- 

Thienyl)cyclohexyl]pyrrolidine 

(7473).

I 

1-Methyl-4-phenyl-4- 

propionoxypiperidine (9661).

I 

1-(2-Phenylethyl)-4-phenyl-4- 

acetoxypiperidine (9663).

I 

2,5-Dimethoxy-4-(n)- 

propylthiophenethylamine 

(7348).

I 

2,5-Dimethoxy-4- 

ethylamphetamine (7399).

I 

2,5-Dimethoxyamphetamine 

(7396).

I 

3,4,5-Trimethoxyamphetamine 

(7390).

I 

3,4-Methylenedioxyamphetamine 

(7400).

I 

3,4-Methylenedioxy-methamphetamine (7405).I 

3,4-Methylenedioxy-Nethylamphetamine (7404).I 

3-Methylfentanyl (9813) ................ I 

3-Methylthiofentanyl (9833) .......... I 

4-Bromo-2,5- 

dimethoxyamphetamine (7391).

I 

4-Bromo-2,5- 

dimethoxyphenethylamine 

(7392).

I 

4-Methyl-2,5- 

dimethoxyamphetamine (7395).

I 

4-Methylaminorex (cis isomer) 

(1590).

I 

4-Methoxyamphetamine (7411) .... I 

5-Methoxy-3,4- 

methylenedioxyamphetamine 

(7401).

I 

5-Methoxy-N,Ndiisopropyltryptamine (7439).I 

Acetorphine (9319) ....................... I 

Acetyl-alpha-methylfentanyl 

(9815).

I 

Acetyldihydrocodeine (9051) ........ I 

Acetylmethadol (9601) .................. I 

Allylprodine (9602) ........................ I 

Alphacetylmethadol except levoalphacetylmethadol (9603).I 

Alpha-ethyltryptamine (7249) ........ I 

Drug Schedule 

Alphameprodine (9604) ................ I 

Alphamethadol (9605) .................. I 

Alpha-methylfentanyl (9814) ......... I 

Alpha-methylthiofentanyl (9832) ... I 

Alpha-methyltryptamine (7432) ..... I 

Aminorex (1585) ........................... I 

Benzethidine (9606) ...................... I 

Benzylmorphine (9052) ................. I 

Betacetylmethadol (9607) ............. I 

Beta-hydroxy-3-methylfentanyl 

(9831).

I 

Beta-hydroxyfentanyl (9830) ......... I 

Betameprodine (9608) .................. I 

Betamethadol (9609) .................... I 

Betaprodine (9611) ....................... I 

Bufotenine (7433) ......................... I 

Cathinone (1235) .......................... I 

Clonitazene (9612) ....................... I 

Codeine methylbromide (9070) .... I 

Codeine-N-Oxide (9053) ............... I 

Cyprenorphine (9054) ................... I 

Desomorphine (9055) ................... I 

Dextromoramide (9613) ................ I 

Diampromide (9615) ..................... I 

Diethylthiambutene (9616) ............ I 

Diethyltryptamine (7434) ............... I 

Difenoxin (9168) ........................... I 

Dihydromorphine (9145) ............... I 

Dimenoxadol (9617) ..................... I 

Dimepheptanol (9618) .................. I 

Dimethylthiambutene (9619) ......... I 

Dimethyltryptamine (7435) ............ I 

Dioxaphetyl butyrate (9621) ......... I 

Dipipanone (9622) ........................ I 

Drotebanol (9335) ......................... I 

Ethylmethylthiambutene (9623) .... I 

Etonitazene (9624) ....................... I 

Etorphine except HCl (9056) ........ I 

Etoxeridine (9625) ........................ I 

Fenethylline (1503) ....................... I 

Furethidine (9626) ........................ I 

Gamma Hydroxybutyric Acid 

(2010).

I 

Heroin (9200) ................................ I 

Hydromorphinol (9301) ................. I 

Hydroxypethidine (9627) ............... I 

Ibogaine (7260) ............................. I 

Ketobemidone (9628) ................... I 

Levomoramide (9629) ................... I 

Levophenacylmorphan (9631) ...... I 

Lysergic acid diethylamide (7315) I 

Marihuana (7360) ......................... I 

Mecloqualone (2572) .................... I 

Mescaline (7381) .......................... I 

Methaqualone (2565) .................... I 

Methcathinone (1237) ................... I 

Methyldesorphine (9302) .............. I 

Methyldihydromorphine (9304) ..... I 

Morpheridine (9632) ..................... I 

Morphine methylbromide (9305) ... I 

Morphine methylsulfonate (9306) I 

Morphine-N-Oxide (9307) ............. I 

Myrophine (9308) .......................... I 

N,N-Dimethylamphetamine (1480) I 

N-[1-(2-thienyl)methyl-4-piperidyl]- 

N-phenylpropanamide (9834).

I 

N-[1-benzyl-4-piperidyl]-Nphenylpropanamide (9818).I 

N-Benzylpiperazine (7493) ........... I 

N-Ethyl-3-piperidyl benzilate 

(7482).

I 

N-Ethylamphetamine (1475) ......... I 

N-Ethyl-l-phenylcyclohexylamine 

(7455).

I 

mstockstill on PROD1PC66 with NOTICES

Federal Register / Vol. 73, No. 152 / Wednesday, August 6, 2008 / Notices 45783 

Drug Schedule 

N-Hydroxy-3,4- 

methylenedioxyamphetamine 

(7402).

I 

Nicocodeine (9309) ....................... I 

Nicomorphine (9312) .................... I 

N-Methyl-3-piperidyl benzilate 

(7484).

I 

Noracymethadol (9633) ................ I 

Norlevorphanol (9634) .................. I 

Normethadone (9635) ................... I 

Normorphine (9313) ...................... I 

Norpipanone (9636) ...................... I 

Para-Fluorofentanyl (9812) ........... I 

Parahexyl (7374) .......................... I 

Peyote (7415) ............................... I 

Phenadoxone (9637) .................... I 

Phenampromide (9638) ................ I 

Phenomorphan (9647) .................. I 

Phenoperidine (9641) ................... I 

Pholcodine (9314) ......................... I 

Piritramide (9642) ......................... I 

Proheptazine (9643) ..................... I 

Properidine (9644) ........................ I 

Propiram (9649) ............................ I 

Psilocybin (7437) .......................... I 

Psilocyn (7438) ............................. I 

Racemoramide (9645) .................. I 

Tetrahydrocannabinols (7370) ...... I 

Thebacon (9315) .......................... I 

Thiofentanyl (9835) ....................... I 

Tilidine (9750) ............................... I 

Trimeperidine (9646) .................... I 

1-Phenylcyclohexylamine (7460) .. II 

1-Piperidinocyclohexanecarbonitrile (8603).II 

Alfentanil (9737) ............................ II 

Alphaprodine (9010) ..................... II 

Amobarbital (2125) ....................... II 

Amphetamine (1100) .................... II 

Anileridine (9020) .......................... II 

Bezitramide (9800) ....................... II 

Carfentanil (9743) ......................... II 

Codeine (9050) ............................. II 

Dextropropoxyphene, bulk (nondosage forms) (9273).II 

Dihydrocodeine (9120) ................. II 

Dihydroetorphine (9334) ............... II 

Diphenoxylate (9170) .................... II 

Ethylmorphine (9190) ................... II 

Etorphine Hcl (9059) ..................... II 

Fentanyl (9801) ............................. II 

Glutethimide (2550) ...................... II 

Hydrocodone (9193) ..................... II 

Hydromorphone (9150) ................. II 

Isomethadone (9226) .................... II 

Levo-alphacetylmethadol (9648) .. II 

Levomethorphan (9210) ............... II 

Levorphanol (9220) ....................... II 

Lisdexamfetamine (1205) ............. II 

Meperidine (9230) ......................... II 

Meperidine intermediate-A (9232) II 

Meperidine intermediate-B (9233) II 

Meperidine intermediate-C (9234) II 

Metazocine (9240) ........................ II 

Methadone (9250) ........................ II 

Methadone intermediate (9254) ... II 

Methamphetamine (1105) ............. II 

Methylphenidate (1724) ................ II 

Metopon (9260) ............................ II 

Moramide intermediate (9802) ..... II 

Morphine (9300) ........................... II 

Nabilone (7379) ............................ II 

Opium, raw (9600) ........................ II 

Opium extracts (9610) .................. II 

Drug Schedule 

Opium fluid extract (9620) ............ II 

Opium tincture (9630) ................... II 

Opium, granulated (9640) ............. II 

Oxycodone (9143) ........................ II 

Oxymorphone (9652) .................... II 

Pentobarbital (2270) ..................... II 

Phenazocine (9715) ...................... II 

Phencyclidine (7471) .................... II 

Phenmetrazine (1631) .................. II 

Phenylacetone (8501) ................... II 

Piminodine (9730) ......................... II 

Powdered opium (9639) ............... II 

Racemethorphan (9732) ............... II 

Racemorphan (9733) .................... II 

Remifentanil (9739) ...................... II 

Secobarbital (2315) ...................... II 

Sufentanil (9740) .......................... II 

Thebaine (9333) ........................... II 

The company plans to import small 

quantities of the listed controlled 

substances for the National Institute on 

Drug Abuse (NIDA) for research 

activities. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 952(a) 

and determined that the registration of 

Research Triangle Institute to import the 

basic classes of controlled substances is 

consistent with the public interest and 

with United States obligations under 

international treaties, conventions, or 

protocols in effect on May 1, 1971, at 

this time. DEA has investigated 

Research Triangle Institute to ensure 

that the company’s registration is 

consistent with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 952(a) 

and 958(a), and in accordance with 21 

CFR 1301.34, the above named company 

is granted registration as an importer of 

the basic classes of controlled 

substances listed. 

Dated: July 29, 2008. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E8–17966 Filed 8–5–08; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated March 19, 2008 and 

published in the Federal Register on 

March 28, 2008, (73 FR 16719), Sigma 

Aldrich Research Biochemicals, Inc., 4–

3 Strathmore Road, Natick, 

Massachusetts 01760–2447, made 

application by renewal to the Drug 

Enforcement Administration (DEA) to 

be registered as a bulk manufacturer of 

the basic classes of controlled 

substances listed in schedules I and II: 

Drug Schedule 

Cathinone (1235) .......................... I 

Methcathinone (1237) .................. I 

Aminorex (1585) ........................... I 

Alpha-ethyltryptamine (7249) ....... I 

Lysergic acid diethylamide (7315) I 

Tetrahydrocannabinols (7370) ..... I 

4-Bromo-2,5- 

dimethoxyamphetamine (7391).

I 

4-Bromo-2,5- 

dimethoxyphenethylamine 

(7392).

I 

2,5-Dimethoxyamphetamine 

(7396).

I 

3,4-Methylenedioxyamphetamine 

(7400).

I 

N-Hydroxy-3,4-methylenedioxyamphetamine (7402).I 

3,4-Methylenedioxy-Nethylamphetamine (7404).I 

3,4-Methylenedioxymethamphetamine (MDMA) (7405).I 

1-[1-(2-Thienyl)cyclohexyl]piperidine (TCP) (7470).I 

1-Benzylpiperazine (BZP) (7493) I 

Heroin (9200) ............................... I 

Normorphine (9313) ..................... I 

Amphetamine (1100) .................... II 

Methamphetamine (1105) ............ II 

Nabilone (7379) ............................ II 

1-Phenylcyclohexylamine (7460) II 

Phencyclidine (7471) .................... II 

Cocaine (9041) ............................. II 

Codeine (9050) ............................. II 

Diprenorphine (9058) ................... II 

Ecgonine (9180) ........................... II 

Levomethorphan (9210) ............... II 

Levorphanol (9220) ...................... II 

Meperidine (9230) ........................ II 

Metazocine (9240) ........................ II 

Methadone (9250) ........................ II 

Morphine (9300) ........................... II 

Thebaine (9333) ........................... II 

Levo-alphacetylmethadol (9648) .. II 

Carfentanil (9743) ......................... II 

Fentanyl (9801) ............................ II 

The company plans to manufacture 

reference standards. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Sigma Aldrich Research Biochemicals, 

Inc. to manufacture the listed basic 

classes of controlled substances is 

consistent with the public interest at 

this time. DEA has investigated Sigma 

Aldrich Research Biochemicals, Inc. to 

ensure that the company’s registration is 

consistent with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

mstockstill on PROD1PC66 with NOTICES